BioTech

STAT Plus: Beam Therapeutics raises $180 million in IPO

Beam Therapeutics (BEAM), a Cambridge, Mass., genome-editing startup, raised $180 million in an preliminary public providing Wednesday after rising the variety of shares it supplied to traders by 48 p.c.

The startup supplied 10.6 million shares at $17, the excessive finish of the anticipated vary of $15 to $17 a share. The corporate initially filed to lift $100 million by providing 6.three million shares at $15 to $17 earlier than rising its shares by practically half early Wednesday.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker